
Contents
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
General principles General principles
-
Intracranial pressure (ICP) Intracranial pressure (ICP)
-
Causes of raised ICP Causes of raised ICP
-
Cerebral perfusion pressure (CPP) Cerebral perfusion pressure (CPP)
-
Cerebral blood flow Cerebral blood flow
-
-
Measuring intracranial pressure Measuring intracranial pressure
-
Anaesthesia in the presence of raised ICP Anaesthesia in the presence of raised ICP
-
Management aims Management aims
-
Specific measures to decrease ICP Specific measures to decrease ICP
-
-
Anaesthetic agents and ICP Anaesthetic agents and ICP
-
-
Craniotomy Craniotomy
-
Preoperative Preoperative
-
Perioperative Perioperative
-
Postoperative Postoperative
-
Special considerations Special considerations
-
-
Ventriculo-peritoneal shunt Ventriculo-peritoneal shunt
-
Preoperative Preoperative
-
Perioperative Perioperative
-
Postoperative Postoperative
-
Special considerations Special considerations
-
-
Evacuation of traumatic intracranial haematoma Evacuation of traumatic intracranial haematoma
-
Preoperative Preoperative
-
Perioperative Perioperative
-
Postoperative Postoperative
-
Special considerations Special considerations
-
Postoperative and ICU management of the head-injured patient Postoperative and ICU management of the head-injured patient
-
-
Pituitary surgery Pituitary surgery
-
Preoperative Preoperative
-
Perioperative Perioperative
-
Postoperative Postoperative
-
Special considerations Special considerations
-
-
Posterior fossa surgery Posterior fossa surgery
-
Preoperative Preoperative
-
Perioperative Perioperative
-
Patient positioning Patient positioning
-
Postoperative Postoperative
-
Special considerations Special considerations
-
-
Awake craniotomy Awake craniotomy
-
Preoperative Preoperative
-
Perioperative Perioperative
-
Postoperative Postoperative
-
Special considerations Special considerations
-
-
Vascular lesions Vascular lesions
-
Intracranial aneurysms Intracranial aneurysms
-
Arteriovenous malformations Arteriovenous malformations
-
-
Complications of aneurysmal subarachnoid haemorrhage (SAH) Complications of aneurysmal subarachnoid haemorrhage (SAH)
-
Neurological complications Neurological complications
-
Rebleeding Rebleeding
-
Delayed neurological deficit (DND) Delayed neurological deficit (DND)
-
Treatment Treatment
-
-
Hydrocephalus Hydrocephalus
-
Other neurological complications Other neurological complications
-
-
Medical complications Medical complications
-
Outcome following subarachnoid haemorrhage Outcome following subarachnoid haemorrhage
-
-
Anaesthesia for vascular lesions Anaesthesia for vascular lesions
-
Preoperative Preoperative
-
Perioperative Perioperative
-
Postoperative Postoperative
-
Arteriovenous malformations (AVMs) Arteriovenous malformations (AVMs)
-
-
Interventional radiology Interventional radiology
-
Intracranial aneurysms Intracranial aneurysms
-
Special considerations Special considerations
-
Complications Complications
-
-
AVM: cerebral and spinal AVM: cerebral and spinal
-
Special considerations Special considerations
-
Complications Complications
-
-
-
Venous air embolism (VAE) Venous air embolism (VAE)
-
Detection of VAE Detection of VAE
-
Prevention Prevention
-
Treatment Treatment
-
Paradoxical air embolism Paradoxical air embolism
-
-
Neurological determination of death Neurological determination of death
-
Preconditions Preconditions
-
Absence of brainstem responses Absence of brainstem responses
-
Other considerations Other considerations
-
-
Organ retrieval from a beating heart donor Organ retrieval from a beating heart donor
-
Pathophysiology of brainstem death Pathophysiology of brainstem death
-
Preoperative Preoperative
-
Perioperative Perioperative
-
Special considerations Special considerations
-
Further reading Further reading
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Cite
Alex Manara and Samantha Shinde
General principles 404
Craniotomy 408
Ventriculo-peritoneal shunt 410
Evacuation of traumatic intracranial haematoma 412
Pituitary surgery 416
Posterior fossa surgery 418
Awake craniotomy 422
Vascular lesions 424
Complications of aneurysmal subarachnoid haemorrhage (SAH) 426
Anaesthesia for vascular lesions 428
Interventional radiology 430
Venous air embolism (VAE) 432
Neurological determination of death 434
Organ retrieval from a beating heart donor 436
General principles
Intracranial pressure (ICP)
Normal ICP is 5–12mmHg. Changes in ICP reflect changes in the volume of intracranial contents held within the confines of the skull (brain substance 1200–1600ml, blood 100–150ml, CSF 100–150ml, ECF <75ml). Compensatory mechanisms initially reduce the effect of an intracranial space-occupying lesion on ICP by displacing CSF into the spinal subarachnoid space, increasing absorption of CSF, and reducing intracranial blood volume. Eventually these mechanisms are overwhelmed and further small increases in intracranial volume result in a steep rise in intracranial pressure (see Figure 16.1). If a lesion develops slowly it may reach a relatively large volume before causing a significant rise in ICP. A lesion that appears relatively small on a CT scan may have developed quickly, allowing little time for compensation.

Causes of raised ICP
Increased brain substance: tumour, abscess, haematoma
Increased CSF volume: hydrocephalus, benign intracranial hypertension, blocked shunt
Increased blood volume:
Increased cerebral blood flow (CBF): hypoxia, hypercarbia, volatile anaesthetic agent
Increased cerebral venous volume: increased thoracic pressure, venous obstruction in the neck, head-down tilt, coughing
Increased extracellular fluid: cerebral oedema
Cerebral perfusion pressure (CPP)
CPP is the effective pressure that results in blood flow to the brain.
CPP = MAP – (ICP + VP)
Venous pressure (VP) at the jugular bulb is usually zero or less, and therefore CPP is related to ICP and mean arterial pressure (MAP) alone. The CPP therefore varies with the patient's MAP, but CBF is maintained constant by autoregulation.
Cerebral blood flow
Autoregulation maintains CBF between a MAP of 50 and 140mmHg. Outside these limits CBF varies passively with perfusion pressure. In patients with chronic hypertension the lower and upper limits of autoregulation are higher than normal, so that a MAP that may be adequate in a normal patient may lead to cerebral ischaemia in the hypertensive patient. Autoregulation is also impaired or abolished acutely in the presence of a brain tissue acidosis, i.e. with hypoxia, hypercarbia, acute intracranial disease, and following head injury.
CBF varies with:
Metabolism: CBF is primarily determined by the metabolic demands of the brain. It increases during epileptic seizures and with pain/anxiety. It is reduced in coma, hypothermia, and with anaesthetic agents.
Carbon dioxide tension: hypocapnia results in cerebral vasoconstriction and a reduction in CBF. The greatest effect is at normal PaCO2, where a change of 1kPa (7.5mmHg) results in a 30% change in blood flow. MAP modifies the response of CBF to hyperventilation. High perfusion pressures increase the responsiveness to hyperventilation, whereas hypotension of 50mmHg abolishes the effect of PaCO2 on CBF.
Oxygen tension: PaO2 is not an important determinant of CBF, a value of <7kPa (53mmHg) being required before cerebral vasodilatation occurs.
Temperature: hypothermia reduces cerebral metabolism by ∼5% per degree centigrade, thereby reducing CBF.
Viscosity: there is no effect on CBF when the haematocrit is between 30 and 50%. CBF will increase with reduced viscosity outside this range.
Anaesthetic agents: see below.
Measuring intracranial pressure
Ventricular: a catheter inserted into a lateral ventricle via a burr hole is the gold standard for measuring ICP. This also allows drainage of CSF as a treatment option. Risks include haemorrhage at insertion and ventriculitis with prolonged use. Insertion may be difficult in patients with cerebral oedema and small ventricles.
Intraparenchymal: micro-miniature silicone strain gauge monitors can be inserted into the brain parenchyma to monitor ICP. They are accurate and relatively easy to insert even by non-neurosurgical staff. They are currently the most common technique used to measure ICP
Anaesthesia in the presence of raised ICP
Symptoms and signs to identify patients with a raised ICP preoperatively:
Early: headache, vomiting, seizures, focal neurology, papilloedema.
Late: increasing blood pressure and bradycardia. Agitation, drowsiness, coma, Cheyne Stokes breathing, apnoea. Ipsilateral then bilateral pupillary dilatation, decorticate then decerebrate posturing.
Investigations: evaluate CT/MRI scans for the presence of generalised oedema, midline shift, acute hydrocephalus, and site/size of any lesion.
Management aims
Do not increase ICP further.
Avoid increasing CBF by avoiding hypercarbia, hypoxia, hypertension, and hyperthermia. Use IPPV to control PaCO2 and ensure good oxygenation, adequate analgesia, and anaesthetic depth.
Avoid increasing venous pressure. Avoid coughing and straining, the head-down position, and obstructing neck veins with ET tube ties.
Prevent further cerebral oedema. While patients are generally fluid restricted, it is important to maintain intravascular volume and CPP. Do not use hypotonic solutions—fluid flux across the blood–brain barrier is determined mainly by plasma osmolality not oncotic pressure. Maintenance of a high normal plasma osmolality is essential.
Maintain CPP: hypotension will decrease CPP in the presence of a raised ICP. Control blood pressure using fluids and vasopressors as necessary. Aim for a CPP >70mmHg.
Avoid anaesthetic agents that increase ICP (see below).
Specific measures to decrease ICP
Reduce cerebral oedema using osmotic or loop diuretics, or both. Give mannitol 0.25–1g/kg over 15min or furosemide 0.25–1mg/kg. Insert a urinary catheter in patients receiving diuretics.
Modest hyperventilation to PaCO2 of 4.0–4.5kPa (30–34mmHg) has a transient effect in reducing ICP for 24hr. Excessive hyperventilation results in cerebral ischaemia and a loss of autoregulation. Note: ETCO2 is lower than PaCO2.
Corticosteroids reduce oedema surrounding tumours and abscesses but have no role in head injury. They take several hours to work. Dexamethasone 4mg 6-hourly is often given electively preoperatively.
CSF may be drained via a ventricular or lumbar drain.
Position the patient with a head-up tilt of 30° to reduce central venous pressure. Ensure that MAP is not significantly reduced as the overall result could be a reduction in CPP.
Anaesthetic agents and ICP
Volatile agents uncouple metabolism and flow, reducing cerebral metabolism while increasing CBF and ICP. They abolish autoregulation in sufficient doses. Halothane causes the greatest increase in ICP and isoflurane the least. ICP is unaffected by concentrations of <1 MAC of isoflurane, sevoflurane, and desflurane. Enflurane may cause seizures and has no place in neuroanaesthesia. Nitrous oxide is a weak cerebral vasodilator increasing CBF and therefore ICP. It has also been shown to increase cerebral metabolic rate.
IV anaesthetic agents all decrease cerebral metabolism, CBF, and ICP with the exception of ketamine. Ketamine has some neuroprotective properties but is considered contraindicated in neurosurgery. CO2 reactivity and autoregulation of the cerebral circulation are well maintained during propofol/thiopental anaesthesia.
Other drugs:
Suxamethonium causes a rise in ICP through muscle fasciculation increasing venous pressure. This effect is of little clinical relevance. Suxamethonium should still be used when rapid intubation is required in the presence of a potentially full stomach (e.g. head injury).
Opioid analgesics have little effect on CBF and ICP if hypercapnia is avoided. CO2 reactivity is maintained.
Craniotomy
Procedure | Excision or debulking of tumour, brain biopsy, drainage of cerebral abscess |
Time | 1–12hr |
Pain | +/+++ |
Position | Supine, head-up tilt, or lateral decubitus |
Blood loss | 0–2000ml, G&S, or X-match 2U |
Practical techniques | ETT, IPPV, art line, CVP |
Procedure | Excision or debulking of tumour, brain biopsy, drainage of cerebral abscess |
Time | 1–12hr |
Pain | +/+++ |
Position | Supine, head-up tilt, or lateral decubitus |
Blood loss | 0–2000ml, G&S, or X-match 2U |
Practical techniques | ETT, IPPV, art line, CVP |
Preoperative
Assess the patient for symptoms and signs of raised ICP. Document any neurological deficits. Assess the gag reflex.
Intracranial tumours may be metastatic: primary sites include the lung, breast, thyroid, and bowel.
Check CT/MRI scans—the duration and complexity of the procedure are determined by the size, site, and vascularity of lesions being excised.
Patients receiving diuretics or who have been vomiting may have disordered electrolytes. Patients receiving dexamethasone may be hyperglycaemic.
Restrict IV fluids to 30ml/kg/d if cerebral oedema present. Avoid glucose-containing solutions. They may cause hyperglycaemia, which is associated with a worse outcome after brain injury. They also reduce osmolality, resulting in increased cerebral oedema.
Ensure graduated compression stockings are fitted to prevent DVT.
Prophylactic or therapeutic phenytoin may be required (a loading dose of 15mg/kg followed by a single daily dose of 3–4mg/kg).
Perioperative
Patients undergoing burr hole biopsy require standard monitoring. Those scheduled for craniotomy also need arterial line/CVP, neuromuscular monitoring, and core temperature. Insert a urinary catheter for long procedures and in patients who receive diuretics.
Induce with thiopental 3–5mg/kg or propofol 2–3mg/kg combined with remifentanil (0.2–0.5µg/kg/min). Give IV induction agents slowly to avoid reducing BP and CPP. A non-depolarising relaxant is used to facilitate intubation. Remifentanil usually attenuates the hypertensive response to intubation—if not use additional agents such as lidocaine 1.5mg/kg or a β-blocker (labetalol 5mg increments). Use an armoured ETT to prevent kinking and secure in place with tapes as ties may cause venous obstruction. Protect the eyes.
Avoid N2O. Maintain anaesthesia using either volatile agent (sevoflurane/isoflurane <1 MAC) or TCI propofol (3–6µg/ml). Remifentanil infusion is continued at a lower rate (0.15–0.25µg/kg/min) titrated to response. Top-up doses of muscle relaxants are rarely required when remifentanil is used. In the absence of remifentanil use fentanyl 5µg/kg at induction followed by top-up doses as required or an alfentanil infusion (25–50µg/kg/hr).
Patients may be placed in the supine or lateral position. Avoid extreme neck flexion or rotation, which may impair cerebral venous return, and maintain a head-up tilt. If the head is turned for surgery, support the shoulder to reduce the effect on neck veins.
Application of the Mayfield 3-point fixator to secure the head can cause a marked hypertensive response. Pin sites can be infiltrated with local anaesthetic and if necessary give a further dose of remifentanil (0.5–1µg/kg) or propofol (0.5–1mg/kg).
Aim for normotension during most procedures. Modest hypotension may infrequently be required to improve surgical field. Mild hypocapnia is used in tumour surgery. Aim for PaCO2 of 4.0–4.5kPa (30–34mmHg).
Avoid hypotonic solutions for fluid maintenance. Replace blood loss with colloid or blood.
Maintain normothermia. Hypothermia is rarely indicated.
Use intermittent pneumatic compression device to the calves or feet.
Closure of the dura, bone flap, and scalp takes at least half an hour. Administer IV morphine at this stage to provide analgesia when the remifentanil is stopped. Sudden hypertension on awakening may be treated with small boluses of labetalol. Avoid coughing if possible.
Postoperative
Further incremental doses of IV morphine may be required in the immediate postoperative period in the recovery area.
Many routine craniotomies can be managed postoperatively on an adequately staffed neurosurgical ward. Continued monitoring of the patient's conscious level and neurological state is essential. Consider postoperative sedation and ventilation if there is continuing cerebral oedema or if the patient was severely obtunded preoperatively.
On return to the ward the majority of patients will experience pain in the mild to moderate range after craniotomy. At this stage codeine phosphate (60–90mg) combined with regular paracetamol is usually sufficient in >90% of patients. If not PCA with morphine may be used.
Special considerations
NSAIDs should be used only for postoperative analgesia after careful consideration. While they reduce opioid requirements and enhance opioid analgesia, they also increase bleeding time—a postoperative intracranial haematoma is potentially disastrous. Many patients will have also received diuretics and are potentially hypovolaemic.
A central line is indicated for the majority of craniotomies to allow measurement of CVP, infusion of vasoactive drugs, and aspiration of air in the case of venous air embolism.
Ventriculo-peritoneal shunt
Procedure | CSF drainage for hydrocephalus |
Time | 45–120min |
Pain | ++ |
Position | Supine, head-up tilt |
Blood loss | Minimal |
Practical techniques | ETT, IPPV |
Procedure | CSF drainage for hydrocephalus |
Time | 45–120min |
Pain | ++ |
Position | Supine, head-up tilt |
Blood loss | Minimal |
Practical techniques | ETT, IPPV |
Shunts are inserted for hydrocephalus. CSF is diverted from the cerebral ventricles to other body cavities, from where it is absorbed. Most commonly a ventriculo-peritoneal shunt is created, more rarely a ventriculo-atrial or ventriculo-pleural shunt. An occipital burr hole enables a tube to be placed into the lateral ventricle. This is then tunnelled subcutaneously down the neck and trunk and inserted into the peritoneal cavity through a small abdominal incision. A flushing device can be placed in the burr hole to keep the system clear, and a valve system is incorporated to prevent CSF draining too rapidly with changes in posture.
Preoperative
As for craniotomy ( p. 408).
Many patients requiring shunts are children and the usual paediatric considerations apply.
Patients often have raised intracranial pressure.
Emergency cases may have a full stomach, requiring a rapid sequence induction.
Perioperative
Shunt procedures are shorter and simpler than craniotomies. Use routine monitoring. Arterial and central venous lines are not required.
Antibiotic treatment or prophylaxis is required and strict antisepsis protocols are normally followed to reduce the incidence of shunt infection.
Advancing the trocar to allow tunnelling of the shunt is particularly stimulating. Additional analgesia and/or muscle relaxation is often required at this stage.
Postoperative
Any deterioration in the patient's conscious level is an indication for CT scan to exclude shunt malfunction or subdural haematoma.
Special considerations
Patients are at risk of intracranial haemorrhage if CSF is drained too rapidly.
Shunts often block or become infected, requiring revision.
Watch for signs of pneumothorax as the trocar is placed subcutaneously.
Evacuation of traumatic intracranial haematoma
Procedure | Evacuation of extradural or subdural haematoma |
Time | 1.5–3hr |
Pain | +/+++ |
Position | Supine, head-up |
Blood loss | 200–2000ml, X-match 2U |
Practical techniques | ETT, IPPV, art line, CVP |
Procedure | Evacuation of extradural or subdural haematoma |
Time | 1.5–3hr |
Pain | +/+++ |
Position | Supine, head-up |
Blood loss | 200–2000ml, X-match 2U |
Practical techniques | ETT, IPPV, art line, CVP |
Intracranial haematoma may be extradural, subdural, or intracerebral.
Extradural: urgent evacuation is required and certainly within an hour of pupillary dilation. The haematoma is usually the result of a tear in the middle meningeal artery. It is virtually always associated with a skull fracture, except in children, when the fracture may be absent.
Subdural haematoma results from bleeding from the bridging veins between the cortex and dura. Early evacuation of acute subdural haematoma improves outcome. Chronic subdural haematomas may occur in the elderly, often after trivial injury. They present insidiously with headaches and confusion and can be evacuated via burr hole under local anaesthesia.
Intracerebral haematoma occurs in hypertensive individuals, as a complication of treatment with warfarin, or as a result of bleeding from an intracranial aneurysm.
Preoperative
As for head injury ( p. 872).
Most patients will have a reduced or deteriorating GCS.
Intracranial pressure is usually raised.
Patients may have a full stomach, requiring rapid sequence induction. Insert an orogastric tube after intubation.
Check blood clotting profile and the availability of blood products prior to surgery.
Perioperative
As for craniotomy ( p. 408).
Patients require standard monitoring, including invasive blood pressure and CVP monitoring.
Ensure smooth induction and normotension. Maintain CPP using fluids and vasopressors if necessary. Assume that the ICP is 20mmHg—the minimum acceptable MAP is therefore 80mmHg to achieve a CPP of 60mmHg.
Ensure head-up tilt; avoid nitrous oxide, ventilate to an ETCO2 of 4.0kPa (30mmHg) and give mannitol (0.5–1g/kg) or 5% saline (100ml) and furosemide (0.25–1mg/kg) as required.
Once decompression has occurred there may be a decrease in systemic blood pressure, which can usually be treated with volume replacement.
Postoperative
Most patients should be transferred to ICU. Further management should be guided by a protocol to maintain CPP and prevent secondary insults to the brain (see below).
Special considerations
Postoperative and ICU management of the head-injured patient
Management of head-injured patients is similar for postoperative patients and those not requiring surgery. Patients are best managed using a protocol designed primarily to maintain an adequate CPP/cerebral oxygenation and control ICP. It involves identifying and treating causes of secondary brain insults.
Causes of secondary insult are:
Intracranial—haematoma, oedema, convulsions, hydrocephalus, abscess, hyperaemia
Systemic—hypotension, hypoxia, hyponatraemia, pyrexia, anaemia, sepsis, hypercarbia, hyperglycaemia
Steroids should not be administered to patients following severe head injury.

Guidelines for managing adults with severe head injuries in ICU.
Pituitary surgery
Procedure | Trans-sphenoidal hypophysectomy |
Time | 90–180min |
Pain | ++ |
Position | Supine, head-up tilt |
Blood loss | Nil usually, but large if venous sinus disrupted, G&S |
Practical techniques | ETT, IPPV, art line |
Procedure | Trans-sphenoidal hypophysectomy |
Time | 90–180min |
Pain | ++ |
Position | Supine, head-up tilt |
Blood loss | Nil usually, but large if venous sinus disrupted, G&S |
Practical techniques | ETT, IPPV, art line |
Pituitary tumours account for 15% of all intracranial tumours. They present with either hypersecretion of hormones (acromegaly/Cushing's syndrome) or mass effects (headaches, visual field defects, hydrocephalus, hypopituitarism). Hypophysectomy is undertaken urgently if the patient's sight is deteriorating rapidly.
Preoperative
Special considerations for acromegalic patients (see also p. 162):
Possible airway compromise due to macroglossia, prognathism, and hypertrophy of epiglottis/vocal cords
Hypertension and left ventricular hypertrophy
Sleep apnoea, diabetes mellitus
Special considerations for Cushing's patients (see also p. 174):
Hypertension, truncal obesity
Electrolyte abnormalities (hypokalaemia, hyperglycaemia)
Steroid cover necessary pre- and postoperatively
Perioperative
As for craniotomy ( p. 408).
A throat pack should be inserted following intubation. Moffett's solution ( p. 634) may be instilled into each nostril to improve surgical conditions.
Surgical access is via the sphenoidal air sinuses.
If there is suprasellar extension a lumbar drain is inserted into the CSF. The anaesthetist may be required to instil a volume of sterile saline to advance the tumour into the operative field.
Major haemorrhage may occur if there is disruption of the cavernous sinus/carotid arteries which lie lateral to the pituitary gland.
Postoperative
Codeine phosphate is the analgesic of choice.
Diabetes insipidus may occur in up to 50% of patients. It is managed initially with IV desmopressin (0.25–1µg).
Cerebrospinal rhinorrhoea may occur. It is usually self-limiting, but, if persistent, intermittent CSF drainage via a lumbar drain may be required.
Special considerations
Patients with preoperative pan-hypopituitarism or who develop postoperative endocrine disturbances should be referred to an endocrinologist for advice on hormone replacement. If a craniotomy is planned rather than a transpheniodal approach, refer to p. 408.
Posterior fossa surgery
Procedure | Excision or debulking of tumour, vascular procedures, foramen magnum decompression |
Time | 3–14hr |
Pain | +/+++ |
Position | See below |
Blood loss | 100–2000ml, G&S |
Practical techniques | ETT, IPPV, art line, CVP, consider monitoring for venous air embolism |
Procedure | Excision or debulking of tumour, vascular procedures, foramen magnum decompression |
Time | 3–14hr |
Pain | +/+++ |
Position | See below |
Blood loss | 100–2000ml, G&S |
Practical techniques | ETT, IPPV, art line, CVP, consider monitoring for venous air embolism |
The posterior fossa lies below the tentorium cerebelli and contains the pons, medulla, and cerebellum. Within the brainstem lie the main motor and sensory pathways, the lower cranial nerve nuclei, and the centres that control respiration and cardiovascular function. An increase in pressure in this area results in decreased consciousness, hypertension, bradycardia, respiratory depression, and loss of protective airway reflexes. The exit pathways for CSF from the ventricular system are also located here and obstruction results in hydrocephalus. Space-occupying lesions and surgical disturbance in this area can therefore have a profound physiological impact.
Preoperative
Patients with posterior fossa lesions may have a reduced level of consciousness and impaired airway reflexes. Bulbar palsy may lead to silent aspiration. Pulmonary function must be assessed.
Assess intracranial pressure—may be raised. If hydrocephalus is present, ventricular drainage may be required before the definitive procedure.
Assess fluid status—may be dehydrated if vomiting. A reduced intravascular volume will result in hypotension on induction or if placed in the sitting position.
Check electrolytes and glucose, particularly if taking diuretics or steroids.
Assess cardiovascular function, particularly the presence of untreated hypertension, postural hypotension, and septal defects.
Perioperative
As for craniotomy ( p. 408).
Insert an NG tube if risk of postoperative bulbar dysfunction.
Further specialised monitoring is required for posterior fossa surgery, including monitoring for venous air embolism ( p. 432) and nerve tract injury. The appropriate electrophysiological monitor used to detect nerve tract injury depends upon the neural pathway at risk during the procedure. Spontaneous or evoked electromyographic activity, somatosensory evoked potentials, or brainstem auditory evoked potentials are frequently monitored.
Lumbar CSF drainage is occasionally requested to improve surgical conditions and to reduce the incidence of postoperative CSF leaks.
Avoid N2O—it increases cerebral metabolic rate and CBF and may worsen the outcome of air embolism. Finally, there is a risk that any residual intracranial air will increase in volume and cause postoperative pneumocephalus.
Surgical interference with vital centres may result in sudden and dramatic cardiovascular changes. Inform the surgeon—more gentle retraction or dissection usually resolves the problem. Use drugs such as atropine and β-blockers only if absolutely necessary as they make the interpretation of further changes difficult.
Patient positioning
Surgical access to the posterior fossa requires the patient to be sitting, prone, or lateral. Careful attention is required in positioning the patient as procedures are often prolonged.
Sitting position: use of this position is declining. It provides optimum access to midline lesions, improves cerebral venous drainage, and lowers intracranial pressure. However, complications include haemodynamic instability, venous air embolism, and the possibility of paradoxical air embolism, pneumocephalus, and quadriplegia. Absolute contraindications include cerebral ischaemia when upright and awake, and the presence of a patent ventriculo-atrial shunt or patent foramen ovale (should be screened preoperatively). Relative contraindications are uncontrolled hypertension, extremes of age, and COPD. To achieve this position the head and shoulders are gradually elevated with the neck partially flexed and the forehead resting on a horseshoe ring mounted on a frame. Avoid excessive head flexion since this can cause jugular compression, swelling of the tongue and face, and cervical cord ischaemia.
Prone position: allows good surgical access without the risks associated with the sitting position. Abdominal compression should be avoided as it results in increased cerebral venous pressure. This is achieved by adequately supporting the chest and pelvis.
Lateral position: the lateral or ‘park bench’ position is particularly suitable for lateral lesions such as acoustic neuroma and operations on a cerebellar hemisphere. The neck is flexed and the head rotated towards the floor ensuring that the jugular veins are not obstructed. Pressure points over the shoulder, greater trochanter, and peroneal nerves should be protected.
Postoperative
Most patients can be safely extubated and managed on a properly staffed neurosurgical ward postoperatively.
Airway obstruction can occur after posterior fossa surgery due to macroglossia, partial damage to the vagus, and excessive flexion of the cervical spine.
Surgery on medulla or high cervical lesions carries a significant risk of postoperative impairment of respiratory drive.
The patient should be admitted to ICU for ventilation if the preoperative state was poor, the surgical resection was extensive, there is significant cerebral oedema, or there are intraoperative complications.
Special considerations
Acoustic neuroma: the facial nerve is particularly vulnerable and is monitored using electromyographic needles placed over the face. This allows the surgeon to identify when the nerve is at risk. Neuromuscular blockade should be used only at induction to allow intubation. Often 8th nerve function is also monitored to preserve any residual hearing. This requires a constant level of anaesthesia so that neurophysiological changes can be attributed to surgery rather than variations in anaesthetic depth. These requirements are best met using a remifentanil infusion combined with a constant level of anaesthesia using a low concentration of an inhalation agent or a propofol infusion.
Venous air embolism (see p. 432).
Postoperative analgesia is managed as for craniotomy.
Tumour | Notes |
Gliomas | Cerebellar astrocytomas, ependymomas, particularly arising from the fourth ventricle |
Medulloblastoma | Often arising from the vermis of the cerebellum, usually in children |
Acoustic neuroma | Arising from the 8th nerve in the cerebello-pontine angle, usually benign |
Haemangioblastoma | Young adults |
Meningiomas Metastatic tumours Abscesses and haematoma | Less common in the posterior fossa |
Vascular lesions | Aneurysms of the superior cerebellar, posterior inferior cerebellar, and vertebral arteries |
Developmental lesions | Arnold–Chiari malformation |
Tumour | Notes |
Gliomas | Cerebellar astrocytomas, ependymomas, particularly arising from the fourth ventricle |
Medulloblastoma | Often arising from the vermis of the cerebellum, usually in children |
Acoustic neuroma | Arising from the 8th nerve in the cerebello-pontine angle, usually benign |
Haemangioblastoma | Young adults |
Meningiomas Metastatic tumours Abscesses and haematoma | Less common in the posterior fossa |
Vascular lesions | Aneurysms of the superior cerebellar, posterior inferior cerebellar, and vertebral arteries |
Developmental lesions | Arnold–Chiari malformation |
Awake craniotomy
Procedure | Epilepsy surgery, excision of tumours in eloquent cortical areas |
Time | 1.5–4hr |
Pain | +/+++ |
Position | See below |
Blood loss | 100–2000ml, G&S |
Practical techniques | LMA, art line, consider monitoring for venous air embolism |
Procedure | Epilepsy surgery, excision of tumours in eloquent cortical areas |
Time | 1.5–4hr |
Pain | +/+++ |
Position | See below |
Blood loss | 100–2000ml, G&S |
Practical techniques | LMA, art line, consider monitoring for venous air embolism |
Awake craniotomy allows intraoperative assessment of the patient's neurological status. It is mainly used to allow accurate mapping of the resection margins in epilepsy surgery, accurate location of electrodes in surgery for movement disorders, and excision of tumours from eloquent areas of the cortex (sensory, motor, speech areas). In tumour surgery the aim is to achieve maximal tumour resection with minimal neurological deficit. It is used most effectively in combination with modern imaging techniques such as 3D navigation systems. Awake craniotomy may be associated with a lower requirement for high-dependency care, shorter length of stay, and reduced costs. In the past a combination of local anaesthesia and sedation was used, but the use of an asleep–awake–asleep technique with a laryngeal mask airway (LMA) is gaining popularity since it is associated with a lower incidence of complications such as oversedation, airway obstruction, hypoventilation, and an uncooperative patient.
Preoperative
As for craniotomy ( p. 408).
Both the neurosurgeon and neuro-anaesthetist must be experienced in awake craniotomy. Appropriate patient selection is essential. The patient must be well informed, motivated, and able to tolerate lying still for the duration of surgery. Confusion, anxiety, and difficulty in communication are contraindications. Obesity, oesophageal reflux, and highly vascular tumours may also cause problems.
The patient should be given a full explanation of the procedures involved.
Premedication is generally avoided, but routine medication should be administered on the day of surgery. Anticonvulsant prophylaxis should be prescribed routinely for all patients and dexamethasone for those undergoing tumour surgery.
Perioperative
Aims are to ensure adequate sedation, analgesia, cardiorespiratory stability, and to avoid hypercarbia and nausea and vomiting, as well as ensuring an awake and co-operative patient when required for intraoperative testing. Many techniques can be used to achieve this. Routine monitoring as for craniotomy should be used, including urinary catheterisation if the procedure is expected to be prolonged.
IV antiemetic prophylaxis is administered routinely (e.g. ondansetron 4mg IV). Anaesthesia is induced and maintained with a target- controlled infusion of propofol and a remifentanil infusion (0.05–1µg/kg/min). The propofol dose is titrated against the patient's responses, haemodynamics, and possibly bispectral index monitoring. The patient's lungs are ventilated using an LMA, allowing monitoring and control of ventilation/PaCO2. This minimises the risks of hypoventilation and airway obstruction, providing good operative conditions. Adequate local anaesthetic infiltration of the Mayfield fixator pin sites and the operative field is essential.
When the tumour is exposed the remifentanil is reduced to 0.005–0.01µg/kg/min to allow return of spontaneous ventilation. When this occurs the LMA is removed and the propofol stopped. Once the resection is complete the patient is re-anaesthetised and the LMA reinserted until the end of the procedure.
Preoperative complications include: seizures, respiratory depression, restlessness, airway obstruction, air embolus, and brain swelling.
Postoperative
Morphine should be administered at the end of the procedure.
Other aspects of postoperative care are as for craniotomy ( p. 408).
Special considerations
Ensure that a calm and quiet atmosphere is maintained in theatre. The patient should be draped in a fashion that allows constant access to the patient's airway and minimises the feeling of claustrophobia.
Bispectral index monitoring may be useful in guiding the target- controlled infusion.
Vascular lesions
Vascular lesions presenting for surgical management are usually either intracranial aneurysms or arteriovenous malformations.
Intracranial aneurysms
Berry aneurysms occur at vessel junctions, cerebral arteries having a weaker, less elastic muscle layer than systemic vessels. They may occur in association with atherosclerosis, polycystic kidneys, hereditary haemorrhagic telangectasia, coarctation of the aorta, and Marfan's, Ehlers–Danlos, and Klinefelter's syndromes. The most common sites are the internal carotid system (41%), the anterior cerebral artery (34%), and the middle cerebral artery (20%).
They are more common in females and 40–60yr olds, and in 25% of cases they are multiple. In the UK, the incidence is 10–28:100 000 per year. The prevalence of aneurysm is 6% of the population in prospective angiographic studies.
Aneurysms do not usually rupture until they are >5mm in diameter. They then present as a subarachnoid or intracerebral haemorrhage. Classic symptoms include sudden onset of severe headache with loss of consciousness, which may be transient in mild cases. Occasionally a patient presents with a focal neurological deficit due to the pressure of an enlarging aneurysm on surrounding structures.
Grading of subarachnoid haemorrhage (World Federation of Neurosurgeons): the grade of SAH influences morbidity and mortality. It is also of value in deciding whether to operate or coil early (grades 1–3) or to delay intervention (grades 4–5).
Arteriovenous malformations
These are dilated arteries and veins with no intervening capillaries.
They may present clinically with subarachnoid haemorrhage or seizures.
High blood flow through such lesions may ‘steal’ blood from surrounding tissue leading to ischaemia.
Complications of aneurysmal subarachnoid haemorrhage (SAH)
Neurological complications
Rebleeding
The initial bleed and subsequent bleeds are the main cause of mortality. The highest risk period is in the first 24hr, during which there is a 4% risk of rebleeding, followed by a further risk of 1.5% per day for the next 4wk.
There is a 60% risk of death with each episode of rebleeding. The main aim of management is to prevent rebleeding by securing the aneurysm either surgically by clipping it or angiographically by obliterating it endoluminally. (See ‘Interventional radiology’, p. 430.)
Surgery was previously delayed for up to 10d to avoid the peak of vasospasm.
The introduction of nimodipine has resulted in earlier surgery, ideally within 72hr. Grade 1–2 patients may be operated upon immediately.
Most aneurysms are now secured by coiling. Cranitomy and clipping are much less common.
Delayed neurological deficit (DND)
DND may present as focal or diffuse deficits and is a major cause of morbidity. It is the second main cause of mortality.
It is associated with vasospasm caused by substances released as the subarachnoid blood undergoes haemolysis. The most likely spasmogenic agent is oxyhaemoglobin.
Although angiographic vasospasm occurs in up to 75% of studied patients, only half of these patients develop DND. Up to 20% of symptomatic patients will develop a stroke or die of vasospasm despite optimal management.
DND peaks 3–14d after the initial bleed. With increasingly early surgery for aneurysms, it is now commonly seen postoperatively.
Treatment
Calcium channel blockers: nimodipine is a relatively selective calcium channel antagonist with effective penetration of the blood–brain barrier. It is started at the time of diagnosis and continued for 3wk (60mg NG/PO 4-hourly). Alternatively it can be administered IV (1mg/hr increasing to 2mg/hr) either centrally or peripherally with a fast flowing IVI. Nimodipine may cause systemic hypotension, which should be managed aggressively with fluids and, if necessary, vasopressors.
Hypertensive, hypervolaemic therapy with or without haemodilution (‘Triple H’ therapy): this is based on the theory that vasospasm can be prevented or reversed by optimising cerebral blood flow. Goals are to increase cardiac output and blood pressure using volume expansion and then vasoactive drugs. The resulting haemodilution may improve cerebral blood flow by reducing viscosity. Disagreement exists as to the fluids/drugs that should be used and which haemodynamic goals to aim for. Suggested values are normal MAP + 15%, CVP >12mmHg, Hct 30–35%. Some centres advocate the use of PA catheters to monitor therapy. Noradrenaline (0.025–0.3µg/kg/min) and dobutamine (2–15µg/kg/min) are used to increase MAP.
In some centres balloon angioplasty or intra-arterial papaverine are also used.
Hydrocephalus
Blood in the subarachnoid space may obstruct drainage of CSF and result in hydrocephalus and raised ICP. Sudden reduction in pressure with the insertion of a ventricular drain may increase the risk of rebleeding by reducing the transmural pressure across the aneurysm. Hydrocephalus must be ruled out by CT scan before attributing neurological deterioration to DND/vasospasm.
Other neurological complications
These include seizures and cerebral oedema.
Medical complications
Life-threatening medical problems occur in nearly 40% of patients and account for about 23% of deaths. Many of the cardiorespiratory complications following SAH are related to the massive sympathetic surge and catecholamine release that follow SAH.
Severe LV dysfunction/cardiogenic shock: nearly 45% of patients have an ejection fraction <50% or regional wall motion abnormalities. Treat with dobutamine.
ECG abnormalities: up to 27% of patients will have ECG changes— T wave inversion, ST segment abnormalities, and Q waves. Strongly associated with a poor neurological grade but not predictive of all causes of mortality.
Neurogenic pulmonary oedema: initially a hydrostatic pulmonary oedema resulting from an increase in pulmonary artery pressure, followed by damage to the pulmonary microvasculature and an increase in pulmonary capillary permeability.
Hyponatraemia: many patients are hypovolaemic and hyponatraemic as a result of excessive atrial natriuretic peptide release. Fluid restriction is inappropriate and it should be managed with sodium repletion.
Other complications include deep vein thrombosis, pneumonia, and hepatic, renal, and GI dysfunction.
Outcome following subarachnoid haemorrhage
Approximately 20% of patients will die from SAH at the time of the initial bleed. Of those who survive to reach hospital a further 15% will die within 24hr and 40% will make a good recovery.
Anaesthesia for vascular lesions
Procedure | Clipping of intracranial aneurysm, endovascular coiling of aneurysm |
Time | >3hr |
Pain | ++/+++ |
Position | Supine, head-up, lateral, or prone |
Blood loss | 200–2000ml; X-match 2U |
Practical techniques | ETT, IPPV, art line, CVP |
Procedure | Clipping of intracranial aneurysm, endovascular coiling of aneurysm |
Time | >3hr |
Pain | ++/+++ |
Position | Supine, head-up, lateral, or prone |
Blood loss | 200–2000ml; X-match 2U |
Practical techniques | ETT, IPPV, art line, CVP |
Clipping an aneurysm involves the use of microsurgery to apply a spring clip across the neck of the aneurysm. Aneurysms arising from branches of the vertebral or basilar arteries require a posterior fossa craniotomy, whereas others may be reached from a frontal or fronto-parietal approach. There is often a need to control the aneurysm prior to clipping by applying a temporary clip to a proximal vessel.
Preoperative
Assess the effects of the haemorrhage and any pre-existing arterial disease on the brain and other organs. See p. 426.
Ensure adequate fluid intake, and that fluid is not being unnecessarily restricted.
Nimodipine treatment should be instituted.
Ensure graduated compression stockings are fitted.
Phenytoin (15mg/kg followed by a single daily dose of 3–4mg/kg) should be prescribed prophylactically for the majority of patients.
Discuss the anticipated difficulty of the surgical approach with the surgeon as it influences the decision to use induced hypothermia, barbiturates, and other forms of cerebral protection.
Perioperative
As for craniotomy (p. 408) but note the following:
Standard monitoring including invasive blood pressure monitoring should be instituted prior to induction. A CVP line can be inserted after induction. It will be useful not only intraoperatively but also in the postoperative period to help guide ‘Triple H’ therapy ( p. 426).
Ensure adequate venous access with large-bore cannulae.
Aim to avoid increases in arterial pressure that may result in aneurysm rupture, but maintain adequate cerebral perfusion pressure. Aim for the preinduction BP ± 10%.
Hypocapnia can result in cerebral ischaemia after SAH and must be avoided. Ventilate to a normal PaCO2.
Maintain core temperature at 36–37oC for all grade 1–3 patients.
Modern neurosurgical practice is to use temporary spring clips rather than induced hypotension. The latter may still be required in difficult cases or if rupture occurs. In this situation aim for a systolic BP of 60–80mmHg. Moderate hypotension may be achieved using isoflurane (up to 1.5MAC). Further hypotension is achieved using labetalol (5–10mg increments). Sodium nitroprusside is rarely used. Hypotension must not be induced in the presence of vasospasm.
If rupture occurs:
Call for help.
Increase IV infusions and start blood transfusion.
Inducing hypotension helps to reduce bleeding.
Ipsilateral carotid compression.
Other cerebral protection measures should be considered electively if temporary clipping of a major cerebral vessel is planned or in case of aneurysm rupture. This includes inducing the administration of thiopental (3–5mg/kg bolus followed by 3–5mg/kg/hr), in which case EEG monitoring should ideally be used to allow titration of the dose to burst suppression. It may be necessary to use a vasopressor to support MAP when infusing thiopental. Inducing hypothermia to a temperature of 32°C is reserved for complex surgical vascular procedures. The patient is cooled using surface devices and rewarmed once the cerebral circulation is restored.
Postoperative
ICU/HDU care is required postoperatively for patients with a poor grade preoperatively, those who had a stormy perioperative course, and those requiring treatment for vasospasm.
Codeine phosphate and regular paracetamol may be prescribed for analgesia.
A decrease in the GCS may indicate vasospasm, intracranial haematoma, or hydrocephalus—perform a CT scan.
Arteriovenous malformations (AVMs)
Surgery is not urgent unless the AVM or a resulting haematoma is causing pressure effects.
The procedure may be associated with significant blood loss—crossmatched blood and adequate IV access are essential.
Blood may be shunted through the AVM, resulting in relative ischaemia to the surrounding tissue. When the lesion is excised, a relative hyperperfusion of surrounding tissue may occur, resulting in cerebral oedema and increased ICP.
There is no risk of vasospasm and when indicated hypotension may be induced with relative safety. This is achieved using isoflurane ± labetalol as outlined for SAH (see above).
In children AVMs can cause high output failure due to intracerebral shunt. CCF may be precipitated by excision of the lesion.
Interventional radiology
Intracranial aneurysms
Most intracranial aneurysms are currently treated by releasing Guglielmi detachable coils (GDC) into the aneurysmal lumen via microcatheters inserted in the femoral artery until occlusion of the aneurysm is achieved. This approach is associated with better independent survival at 1yr than after craniotomy and clipping of the aneurysm. The risk of death is significantly lower in the coiled than the clipped group at 5yr. The risk of late rebleeding is acceptable but higher after coiling than clipping.
The procedure is undertaken in an angiography suite by a neuroradiologist. Ensure a skilled anaesthetic assistant and monitoring facilities as for a GA clipping of aneurysm.
A CVP line is not always necessary. It is preferable to monitor the arterial pressure before induction of anaesthesia, although the femoral artery introducer sheath inserted by the radiologist can be transduced. This provides a reliable mean but overestimates diastolic and underestimates systolic BP.
The patient will need a urinary catheter, temperature monitoring, and warming devices and a wide-bore IV cannula.
A baseline ACT should be measured before starting the procedure. After femoral cannulation an initial dose of heparin (5000IU) is administered followed by an infusion or intermittent doses to keep the ACT 2–3 times baseline. Reversal of heparin with protamine may be required at the end of the procedure.
It is important to maintain a normal MAP and PaCO2. This may be difficult as coiling is not a particularly stimulating procedure.
The induction and maintenance of anaesthesia is the same as for clipping of an aneurysm, although a normal ETT tube or a ProSeal LMA may be used instead of an armoured tube.
Recovery should be smooth and rapid. An incompletely secured aneurysm may require control of MAP postoperatively. Patients who have had neurological complications need to be transferred to a neurological ITU for postoperative ventilation.
Special considerations
Unfamiliar environment, remote site, radiation, radiology equipment, closed skull, contrast and flush, heparin, antiplatelet drugs, and thrombolysis.
In patients with a high risk of a thrombotic event from a coil in the parent vessel, it may be necessary to administer aspirin (500mg IV) and to continue heparin into the postoperative period. Thrombotic events occurring during the procedure are often managed with abciximab.
Complications
Intraoperative vasospasm can result from manipulation of the vessel and is managed by withdrawing the catheter from the vessel and allowing a few minutes for recovery. Alternatively intra-arterial nimodipine may be administered.
Rupture of the aneurysm or haemorrhage is identified by extravasation of contrast. The intracranial haemorrhage may increase ICP and MAP with or without a bradycardia. Aim to reverse the heparin and reduce MAP to the level before the bleed. Measures to reduce ICP (see p. 406 and p. 414) may be required.
Patients with a reduced postoperative GCS should have a CT scan to exclude hydrocephalus or vascular complications. It may be necessary to insert an EVD and transfer to ICU for continued management.
AVM: cerebral and spinal
Embolisation may be used to obliterate an AVM or reduce its size before definitive surgery. This minimises intraoperative bleeding whilst preserving the arterial supply to the brain. Staged procedures are commonly undertaken due to rapid blood flow, multiple fistulae, feeding and draining vessels, and associated aneurysms. The material used is usually a liquid polymer (e.g. Onyx) or glue.
Anaesthesia is as for coiling of aneurysms. Hypotension can cause intracerebral steal, and raised ICP from recent intracranial haemorrhage may worsen hypertension. Controlled hypotension may be used for short periods to produce ‘flow arrest’ through the AVM and enable embolic glue to set rather than be carried straight through. This is achieved by using isoflurane ± labetolol as outlined for SAH (see p. 429).
Special considerations
The femoral artery may need cannulation on multiple occasions. An angio-seal (artificial collagen plug) is therefore not used; instead haemostasis is achieved by applying pressure manually which may take 15–20min. The patient should remain anaesthetised for this to avoid coughing or movement of the leg. Retroperitoneal haematoma may occur.
If the nidus is suitable, the AVM may be treated by radiosurgery in a specialist centre.
Complications
Inadvertent occlusion of normal vessels causing cerebral ischaemia.
Pulmonary embolus from systemic shunting of particulate materials.
Bleeding from incomplete embolisation, perforation of arterial feeders, or rupture of an associated aneurysm. Subtle changes in the dynamics of the fistula may also increase the risk of haemorrhage.
The sudden occlusion of the AVM can result in cerebral hyperperfusion, if the AVM and normal brain share venous drainage. This will result in cerebral oedema and increased ICP.
Venous air embolism (VAE)
VAE can occur whenever the operative site is higher than the right atrium. Its incidence is particularly high during craniotomy in the sitting position, and when the surgeon is dissecting tissues that do not allow veins to collapse despite a negative pressure within them (e.g. the emissary veins in the posterior fossa).
VAE causes pulmonary microvascular occlusion, resulting in increased physiological dead space. Bronchoconstriction may also develop. A large volume of air causes frothing within the right atrium, leading to obstruction of the right ventricular outflow tract and a reduction in cardiac output.
Signs of VAE include hypotension, arrhythmias, increased PA pressure, decreased ETCO2, and hypoxia.
N2O does not increase the risk of VAE but may worsen its outcome.
Detection of VAE
End-tidal CO2 is generally the most useful monitor as it is widely available and sensitive. Air embolism results in a sudden reduction in ETCO2. Hyperventilation, low cardiac output, and other types of embolism will also result in reduction in ETCO2.
Doppler ultrasound is the most sensitive non-invasive monitor. It uses ultra-high-frequency sound waves to detect changes in blood flow velocity and density. Unfortunately, it is not quantitative and does not differentiate between a massive or physiologically insignificant air embolism. Positioning the probe and diathermy interference can prove problematic.
Trans-oesophageal echo allows determination of the amount of air aspirated but is more invasive, difficult to place, and needs expertise to interpret.
Pulmonary artery catheters are invasive but sensitive monitors for VAE. However, an increase in PA pressure is not specific for air.
The least sensitive monitor is a precordial or oesophageal stethoscope to detect a ‘millwheel’ murmur. This is apparent only after massive VAE, which is usually clinically obvious.
Prevention
Avoid the sitting position unless essential.
Elevate the head only as much as necessary.
Ensure adequate blood volume to maintain a positive CVP.
Small amounts of PEEP (5–10cmH2O) may reduce the risk of air entrainment.
A ‘G-suit’ or medical antishock trousers may be used to increase venous pressure and reduce hypotensive episodes in patients in the sitting position.
Treatment
Treatment is supportive.
Inform the surgeon, who should flood the operative field with fluid. This stops further entrainment of air and allows the identification of open veins that can be cauterised or waxed if within bone.
Stop N2O if in use and increase the FiO2 to 1.0.
If possible position the operative site below the level of the heart to increase venous pressure.
Aspirate air from the CVP line. The tip should be placed close to the junction of the SVC and the right atrium.
Support the blood pressure with fluid and vasopressors.
If a large volume of air has been entrained and surgical conditions permit, turn the patient into the left lateral position to attempt to keep the air in the right atrium.
Commence CPR if necessary.
Paradoxical air embolism
Air emboli may enter the systemic circulation through the Thebesian veins in the heart, the bronchial vessels, or a patent foramen ovale. Such defects may be small and not picked up preoperatively.
Small volumes of air in the systemic circulation can have disastrous consequences.
Intracardiac septal defects are an absolute contraindication to surgery in the sitting position.
Neurological determination of death
The most common causes of brainstem death are head injury, intracranial haemorrhage, cerebral tumours, and hypoxic brain injury. To diagnose brainstem death the patient needs to fulfil certain preconditions and have absent brainstem reflexes.
Preconditions
The patient is deeply comatose, apnoeic, and dependent on mechanical ventilation.
The coma must be caused by a known and irreversible cause of brain injury.
Reversible causes for brainstem depression have been excluded: sedatives, muscle relaxants, alcohol, hypothermia, and metabolic or endocrine disturbances.
Absence of brainstem responses
Tests of brainstem reflexes should be performed only when the preconditions are fulfilled.
Pupils are fixed and there is no direct or consensual response to light. The pupils are usually dilated, but this is not essential for the diagnosis.
Corneal reflex is absent.
There is no motor response within the cranial nerve distribution to painful stimuli applied centrally or peripherally. Spinal reflexes may persist in brainstem-dead patients.
Oculo-vestibular reflex is absent. There is no eye movement in response to the injection of 50ml ice-cold water into the external auditory meatus—direct access to the tympanic membrane should be verified using an auroscope. The eyes should be observed for at least 1min after each injection.
There is no gag or cough reflex in response to a suction catheter passed into the pharynx or down the endotracheal tube.
Apnoea is present on disconnection from mechanical ventilation. This test is done last, to avoid unnecessary hypercarbia should any of the other reflexes be present. The patient should be preoxygenated by ventilating with 100% O2 and the minute ventilation reduced to achieve a PaCO2 of 6kPa (45mmHg). The patient is then disconnected and observed continuously for any respiratory movement for 5min. The PaCO2 should be measured and should be high enough to ensure an adequate stimulus to ventilation [>6.7kPa (50mmHg) in a previously normal individual]. Hypoxia is avoided during apnoea by passing a suction catheter down the endotracheal tube and supplying 5–10l/min of oxygen while monitoring the SaO2.
Other considerations
Diagnosis of brainstem death should be made by two medical practitioners trained and experienced in the field. One must be a consultant and the other could be a second consultant or a doctor who has been registered for a minimum of 5yr. Neither should be a member of the transplant team.
The tests must be performed on two occasions separated by an adequate time interval to satisfy all concerned.
The diagnosis should not normally be considered until at least 6hr after the onset of apnoeic coma or 24hr after the restoration of circulation if the cause was cardiac arrest.
Death is confirmed after the second set of tests, but the time of death is recorded as the completion of the first set of brainstem death criteria.
No additional tests are required in the UK, but other countries may require EEG, carotid angiography, or brainstem evoked potentials.
The coroner (Procurator Fiscal in Scotland) needs to be informed of most of these patients due to the underlying diagnosis, and if organ donation is contemplated.
Care of the relatives is essential at this time irrespective of whether the patient is to be an organ donor or not.
Organ retrieval from a beating heart donor
Procedure | Procurement of donor organs via long midline incision and median sternotomy |
Time | Up to 6hr depending on which organs are retrieved |
Pain | N/A |
Position | Supine |
Blood loss | Large fluid losses likely, X-match 4U |
Practical techniques | Usually from ICU IPPV, CVP, and art line |
Procedure | Procurement of donor organs via long midline incision and median sternotomy |
Time | Up to 6hr depending on which organs are retrieved |
Pain | N/A |
Position | Supine |
Blood loss | Large fluid losses likely, X-match 4U |
Practical techniques | Usually from ICU IPPV, CVP, and art line |
Demand for donor organs continues to exceed supply and potential organ donors should be identified and discussed with a donor coordinator. The only absolute contraindications to donation are CJD, HIV, active TB, and recent malignancy in the potential donor.
Pathophysiology of brainstem death
Early, short-lived massive sympathetic outflow occurs during brainstem herniation, causing hypertension, tachycardia, myocardial dysfunction, impaired organ perfusion, and tissue ischaemia.
Autonomic collapse results in a reduction in cardiac output, hypotension, and atropine-resistant bradycardia. Circulatory collapse follows if left untreated.
Deterioration in lung function is common due to neurogenic pulmonary oedema, acute lung injury, and pre-existing disease.
Reduced circulating T3 and T4 with increased peripheral conversion of T4 to reverse T3 causes depletion of myocardial energy stores, myocardial dysfunction, and a global shift to anaerobic metabolism.
Hyperglycaemia is due to reduced circulating insulin and insulin resistance.
Reduced ADH secretion leads to neurogenic diabetes insipidus with hypovolaemia and electrolyte disorders (hypernatraemia, hypermagnesaemia, hypokalaemia, hypophosphataemia, hypocalcaemia).
Release of tissue fibrinolytic agents and plasminogen activators from necrotic brain causes a coagulopathy.
Temperature regulation is lost due to hypothalamic dysfunction resulting in hypothermia.
Preoperative
Check that brainstem death has been confirmed and that agreement to organ donation has been obtained from the relatives and the coroner.
Emphasis in management changes from cerebral resuscitation to optimal organ perfusion and oxygenation.
Ensure intravascular volume resuscitation using continuous CVP monitoring. Avoid overhydration in potential lung donors where a CVP >6mmHg may increase the A–a oxygen gradient and reduce the number of donor lungs that can be retrieved successfully. If hypotension persists despite fluid replacement then an infusion of vasopressin should be started as the first line vasopressor. PAFC and transoesophageal echocardiography are often requested for potential heart donors with high inotrope requirements. They allow assessment of cardiac structure and function, and prevent intravascular overload.
Continue regular chest physiotherapy and suctioning.
If desmopressin has been used to control diabetes insipidus it should be changed to vasopressin (ADH)—restores vascular tone and arterial pressure without a direct myocardial effect.
The use of hormone resuscitation using T3 replacement, methylprednisolone, and vasopressin varies amongst transplant centres. Their use should be guided by the local retrieval team or in-house protocols. High-dose methylprednisolone increases the successful retrieval of lungs for transplantation.
Correct hypernatraemia with 5% glucose (Na+ <155mmol/l). Glucose 4%/sodium chloride 0.18% with potassium chloride should be used to replace normal urinary water and electrolyte losses. Clotting abnormalities should be corrected with clotting factors and platelets.
Central venous access via the right internal jugular vein and left radial arterial access are preferred due to early ligation of the left innominate vein and right subclavian artery respectively.
Order CXR, ECG, echocardiography, and 4-hourly ABGs for potential heart/lung donors.
Target parameters | |
CVP | 4–10mmHg (< 6mmHg for potential lung donors) |
MAP | 60–80mmHg |
PCWP | 10–15mmHg |
Cardiac index | >2.2–2.5 l/min/m2 |
Hb | 10g/dl (Hct 30%) |
SpO2 | >95% (with lowest FiO2 and PEEP) |
Tidal volume | <10ml/kg |
PaCO2 | 4.5–5.5kPa (34–41mmHg) |
Urine output | 1–3ml/kg/hr |
Peak inspiratory pressure | <30cmH2O |
Target parameters | |
CVP | 4–10mmHg (< 6mmHg for potential lung donors) |
MAP | 60–80mmHg |
PCWP | 10–15mmHg |
Cardiac index | >2.2–2.5 l/min/m2 |
Hb | 10g/dl (Hct 30%) |
SpO2 | >95% (with lowest FiO2 and PEEP) |
Tidal volume | <10ml/kg |
PaCO2 | 4.5–5.5kPa (34–41mmHg) |
Urine output | 1–3ml/kg/hr |
Peak inspiratory pressure | <30cmH2O |
. | Bolus . | Infusion . | Action . |
---|---|---|---|
Liothyronine (tri-iodothyronine, T3) | 4µg | 3µg/hr | Reverses myocardial dysfunction and reduces inotrope requirements |
Vasopressin (ADH) | 1U | 0.5–2U/hr | Treats diabetes insipidus and restores vascular tone. Titrated to MAP >60mmHg or SVR 800–1200 dyn.s/cm5 |
Insulin | Sliding scale | To maintain blood sugar 6–9 mmol/l | |
Methylprednisolone | 15mg/kg | Improves oxygenation and increases donor lung procurement by reducing cytokine-mediated cellular injury |
. | Bolus . | Infusion . | Action . |
---|---|---|---|
Liothyronine (tri-iodothyronine, T3) | 4µg | 3µg/hr | Reverses myocardial dysfunction and reduces inotrope requirements |
Vasopressin (ADH) | 1U | 0.5–2U/hr | Treats diabetes insipidus and restores vascular tone. Titrated to MAP >60mmHg or SVR 800–1200 dyn.s/cm5 |
Insulin | Sliding scale | To maintain blood sugar 6–9 mmol/l | |
Methylprednisolone | 15mg/kg | Improves oxygenation and increases donor lung procurement by reducing cytokine-mediated cellular injury |
Perioperative
Standard monitoring plus CVP, arterial line, core temperature, and urine output. Maintain core temperature >35°C. Frequent analysis of ABGs, electrolytes, Hct, glucose, and clotting. Large-bore IV access (right upper limb) is mandatory for replacement of fluid losses (up to 8 litres) with crystalloid, colloid, or red cells (keep Hct >30%).
Need for general anaesthesia is controversial. Many use up to 1 MAC isoflurane or fentanyl (5–7µg/kg) to control reflex pressor responses during surgery. This can also be achieved using labetalol or GTN. Non-depolarising neuromuscular blocking agents are administered to obtund reflex muscular contractions due to the preserved spinal reflexes and improve surgical access. Pancuronium and vecuronium are cardiostable and preferred.
Large and frequent haemodynamic fluctuations occur due to compression of the inferior vena cava, manipulation of the adrenals, and blood/fluid loss. Hypotension is treated with colloid titrated to CVP, vasopressin infusion, and metaraminol (0.5mg increments).
Broad-spectrum antibiotics are given as per local transplant protocol.
Full heparinisation (300IU/kg) should be administered centrally prior to surgical cannulation of the major vessels.
Epoprostenol (5–20ng/kg/min) may be needed for 10min via pulmonary artery if lungs are to be harvested.
PAFC/CVC withdrawn before ligation of SVC.
Note time of aortic cross-clamp as beginning of organ ischaemic time.
At the end discontinue mechanical ventilation/monitoring and remove the ETT after lung inflation and trachea cross-clamp.
The abdominal surgical team continues to operate in circulatory arrest.
Special considerations
Empathy and sensitivity in dealing with the donor's family is paramount throughout the management of the potential organ donor.
The quality of care afforded the multi-organ donor could affect the outcome of more than six recipients.
In the event of cardiac arrest CPR should be commenced, as procurement of liver and kidneys can still proceed rapidly with cross-clamping of the aorta at the diaphragm and infusion of cold preservation solution into the distal aorta and portal vein.
Further reading
Academy of Medical Royal Colleges (2008). A code of practice for the diagnosis and confirmation of death. www.aomrc.org.uk/aomrc/admin/reports/docs/dofd-final.pdf.
Guidelines for adult organ and tissue transplantation (2004). The Intensive Care Society's Working Group on Organ and Tissue Donation. http://www.ics.ac.uk.
Month: | Total Views: |
---|---|
October 2022 | 3 |
December 2022 | 3 |
January 2023 | 3 |
February 2023 | 4 |
March 2023 | 4 |
April 2023 | 1 |
May 2023 | 2 |
June 2023 | 2 |
July 2023 | 2 |
August 2023 | 2 |
September 2023 | 2 |
October 2023 | 2 |
November 2023 | 2 |
December 2023 | 2 |
February 2024 | 1 |
March 2024 | 3 |
April 2024 | 2 |
May 2024 | 1 |
June 2024 | 2 |
July 2024 | 1 |
August 2024 | 3 |
September 2024 | 3 |